Regent Pacific's Deep Longevity Announces U.S. Market Entry in 2026

Reuters
2025/12/01
<a href="https://laohu8.com/S/RPGLF">Regent Pacific</a>'s Deep Longevity Announces U.S. Market Entry in 2026

Regent Pacific Group Ltd. has announced that its subsidiary, Deep Longevity, Inc., will launch a strategic expansion into the United States in the first quarter of 2026. Deep Longevity, a leader in explainable AI-driven aging clocks and longevity science, will establish a U.S.-based sales organization, with the first two salespeople joining on January 1, 2026. The team will focus on building partnerships with longevity platforms, health apps, diagnostic labs, wellness clinics, corporate wellness programs, insurers, employers, and premium health service providers, initially targeting the southeastern region of the U.S. This move positions the company to tap into the world's largest wellness market, valued at over US$6.8 trillion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regent Pacific Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251201-11936218), on December 01, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10